Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity.
about
Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomainNew small-molecule drug design strategies for fighting resistant influenza ACompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsInfluenza virus activation of the interferon systemFragile X mental retardation protein stimulates ribonucleoprotein assembly of influenza A virusThe Rab11 pathway is required for influenza A virus budding and filament formationA Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNACyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathwaysRole of the B Allele of Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.Cyclin T1/CDK9 interacts with influenza A virus polymerase and facilitates its association with cellular RNA polymerase II.Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export.Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins.The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infectionIdentification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein.RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection.Imaging and characterizing influenza A virus mRNA transport in living cells.Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAsTargeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus.Characterisation of influenza A viruses with mutations in segment 5 packaging signals.hnRNP A2/B1 interacts with influenza A viral protein NS1 and inhibits virus replication potentially through suppressing NS1 RNA/protein levels and NS1 mRNA nuclear exportInfluenza virus RNA structure: unique and common features.The role of the influenza virus RNA polymerase in host shut-offTranslating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell.Antiviral strategies against influenza virus: towards new therapeutic approaches.Cytomegalovirus immune evasion by perturbation of endosomal trafficking.Influenza A Virus NS1 Protein Promotes Efficient Nuclear Export of Unspliced Viral M1 mRNA.RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus.Activation of the interferon induction cascade by influenza a viruses requires viral RNA synthesis and nuclear export.Influenza polymerase encoding mRNAs utilize atypical mRNA nuclear exportCHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice lungs during infection.Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells.Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies.Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virionsIdentification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions.Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleo-cytoplasmic transport of its own viral mRNA.Influenza infection modulates vesicular trafficking and induces Golgi complex disruption.RNA-Free and Ribonucleoprotein-Associated Influenza Virus Polymerases Directly Bind the Serine-5-Phosphorylated Carboxyl-Terminal Domain of Host RNA Polymerase II.
P2860
Q27341132-83A58EC0-D76F-4FF4-8A40-F042D8F1B748Q28080554-38A5576F-7900-4D0C-A4EB-FF524964CAF4Q28085400-003BFAD6-0361-4F86-9F89-295EA909CA9AQ28088483-4FA1F534-AC43-4860-AF38-1A5EDB3D456CQ28115134-ED774FA3-6A8B-4AB3-A172-F9C96583CA5EQ28278360-96959344-4F5C-498A-8AA9-F58DE12D9DA2Q28305057-B010726B-74CF-46D9-BCBA-7822C9B71B15Q28483731-B7890376-763F-468C-BB78-2D250DC43687Q30391460-8B35AA0E-6DE2-418C-9E41-89076A61EF4BQ34416639-8C7FC227-85BA-4947-A1B6-4DAE032C9568Q34641761-34335C5C-52F0-4A6A-B78F-B20DA2CDAFB1Q35169989-FEE979BD-2A3E-4479-AE61-60224987A09AQ35192930-BE7501CB-84A1-4454-BA4F-F868D2BB1C25Q35943693-A9906E7B-6FA5-4C2C-B386-01464E443CDDQ36100522-F368D8A9-3BF7-468A-9B3E-FA2E592EF582Q36760084-C19DE011-2ADD-4FD8-9D48-F1C2EA212B0EQ36859268-61DBDEF6-F9EA-4E74-A960-DB24636C5673Q36905953-5A08490C-3BC4-4A66-85A3-83777C6B919DQ36930904-DAD38643-8B05-4D65-8A37-31A1F1CE1036Q36974640-6044E548-234E-4F0D-A45F-C38D138ED582Q37407070-E2B924BC-7447-4794-ACDE-E7B5E6F79DE8Q37548253-ED7CD17C-971F-43B8-88DB-73F130408BF3Q37798025-AE8DCE57-DCF8-4D63-9086-BBBBD3C78522Q37823112-C17E3C4B-D6E5-49FE-A2CE-7E6E7F82191BQ37854496-BFC144EC-AB58-4FD9-820B-6BC1D4582A48Q38117553-F2189E48-C3B3-497A-A58C-705A00957AC3Q38202012-215132D2-C09F-4D28-9081-5DDF590C4DDDQ38255071-BCC544EB-FC27-4009-AEB4-BB37F7494334Q38703166-1711BD1E-8202-4316-A8F1-35BCFD584053Q38763365-1381B961-6477-485F-B1B1-AB731A3FC96CQ38858552-1159F096-E4B7-4485-B429-622A7EA3503EQ38962038-5E90CA9B-0930-4165-A806-AD00654E4FCAQ39194807-A9D93145-2A61-4E0E-BAD9-C809525EECE8Q39781908-139ABAF6-E451-46C7-AA65-42558D06447DQ39801069-742BB607-92ED-4DF5-93A2-42704D6BE087Q39920888-F979B5A5-0299-4149-9C1D-0E831871000FQ40108978-34156573-EB1E-41A4-BC84-A9D7F40383F2Q40135105-96D792D7-3B90-4D53-9C45-5225FD7B66C6Q40399590-1B53C044-01CA-4E89-A9AC-8EB3254914F9Q40705551-4E3E762A-38DE-4255-83C3-420C120595B1
P2860
Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity.
@en
type
label
Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity.
@en
prefLabel
Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity.
@en
P2093
P2860
P1433
P1476
Nuclear export of influenza A virus mRNAs requires ongoing RNA polymerase II activity.
@en
P2093
Eliot K Read
Liz Medcalf
Maria-Joao Amorim
Rosa M Dalton
P2860
P356
10.1111/J.1600-0854.2006.00507.X
P50
P577
2006-11-21T00:00:00Z